Artificial intelligence for dementia—Applied models and digital health
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The use of applied modeling in dementia risk prediction, diagnosis, and prognostics will have substantial public health benefits, particularly as “deep phenotyping” cohorts with multi‐omics health data become available. METHODS: This narrative review synthesizes understanding of applied models and digital health technologies, in terms of dementia risk prediction, diagnostic discrimination, prognosis, and progression. Machine learning approaches show evidence of improved predictive power compared to standard clinical risk scores in predicting dementia, and the potential to decompose large numbers of variables into relatively few critical predictors. RESULTS: This review focuses on key areas of emerging promise including: emphasis on easier, more transparent data sharing and cohort access; integration of high‐throughput biomarker and electronic health record data into modeling; and progressing beyond the primary prediction of dementia to secondary outcomes, for example, treatment response and physical health. DISCUSSION: Such approaches will benefit also from improvements in remote data measurement, whether cognitive (e.g., online), or naturalistic (e.g., watch‐based accelerometry).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
Self-citationRetractedLanguage Models are Few-Shot Learners
Brown, T. B., Mann, B., Ryder, N., Subbiah, M., Kaplan, J., Dhariwal, P., Neelakantan, A., Shyam, P., Sastry, G., Askell, A., et al. (2020) · arXiv · doi:10.48550/arxiv.2005.14165 · Cited by 23,372 · cited 1×
“81 Recent advances in transformers-based large language models, which outperformed traditional recurrent neural networks, and the availability of large population-level electronic textual records hold strong promise to transform and support research in dementia and 82 neurodegenerative disorders.”
BackgroundJack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Fry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
Mahmood, S. S., Levy, D., Vasan, R. S., & Wang, T. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61752-3 · Cited by 1,622 · cited 1×
“Life-course predictors of dementia risk and onset are often addressed using longitudinal studies of aging such as the Health and Retirement Study, 11 Framingham Heart Study, 12 or the Alzheimer’s Disease Neuroimaging Initiative (ADNI 13 ).”
Depression and risk of developing dementia
Byers, A. L., & Yaffe, K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.60 · Cited by 1,265 · cited 1×
“Longitudinal cohort studies have had success in identifying factors from across the life course that predict increased dementia risk, both proximal factors—such as depressive symptoms 14 —and factors from early life such as low educational attainment.”
Triangulation in aetiological epidemiology
Lawlor, D. A., Tilling, K., & Davey Smith, G. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw314 · Cited by 1,129
Chen, Z., Chen, J., Collins, R., Guo, Y., Peto, R., Wu, F., Li, L., & on behalf of the China Kadoorie Biobank (CKB) collaborative group (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr120 · Cited by 1,034 · cited 1×
“108 At the population level there are issues around interpretability— why have some risk factors/features been highlighted, and are those variables necessarily causal?”
Total daily physical activity and the risk of AD and cognitive decline in older adults
Buchman, A. S., Boyle, P. A., Yu, L., Shah, R. C., Wilson, R. S., & Bennett, D. A. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d35 · Cited by 730 · cited 1×
“64 Recentstudieshavefocusedonmeasuringthevolumeofphysicalactiv-ity, such as step counts or time spent walking.”
Manipulating and Measuring Model Interpretability
Poursabzi-Sangdeh, F., Goldstein, D. G., Hofman, J. M., Wortman Vaughan, J. W., & Wallach, H. (2021) · Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems · doi:10.1145/3411764.3445315 · Cited by 728
Manipulating and Measuring Model Interpretability
Poursabzi-Sangdeh, F., Goldstein, D. G., Hofman, J. M., Vaughan, J. W., & Wallach, H. (2018) · arXiv · doi:10.48550/arxiv.1802.07810 · Cited by 711
Robust research needs many lines of evidence
Munafò, M. R., & Davey Smith, G. (2018) · Nature · doi:10.1038/d41586-018-01023-3 · Cited by 666
Association of sleep duration in middle and old age with incidence of dementia
Sabia, S., Fayosse, A., Dumurgier, J., van Hees, V. T., Paquet, C., Sommerlad, A., Kivimäki, M., Dugravot, A., & Singh-Manoux, A. (2021) · Nature Communications · doi:10.1038/s41467-021-22354-2 · Cited by 628
Age, APOE and sex: triad of risk of Alzheimer’s disease.
Riedel, B. C., Thompson, P. M., & Brinton, R. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.012 · Cited by 627
Applications of machine learning to diagnosis and treatment of neurodegenerative diseases
Myszczynska, M. A., Ojamies, P. N., Lacoste, A. M. B., Neil, D., Saffari, A., Mead, R., Hautbergue, G. M., Holbrook, J. D., & Ferraiuolo, L. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0377-8 · Cited by 595
Palmqvist, S., Tideman, P., Cullen, N., Zetterberg, H., Blennow, K., Initiative, T. A. D. N., Dage, J. L., Stomrud, E., Janelidze, S., Mattsson-Carlgren, N., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01348-z · Cited by 524 · cited 1×
“8 Using various classification models, ranging from linear logistic regression to non-linear gradient boosting trees, bloodproteomicbiomarkerscanpredictcognitiveimpairment 9 includ-ingpotentiallyasanefficienttoolforpre-screeningandrecruitmentfor clinical trials.”
Smith, M. T., McCrae, C. S., Cheung, J., Martin, J. L., Harrod, C. G., Heald, J. L., & Carden, K. A. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7230 · Cited by 483
Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0084-2 · Cited by 476 · cited 1×
“Critically, tools must be accessible for scalable adoption in terms of cost, ease of implementation, and use.”
Body mass index and risk of dementia: analysis of individual-level data from 1·3 million individuals
Kivimäki, M., Luukkonen, R., Batty, G. D., Ferrie, J. E., Pentti, J., Nyberg, S. T., Shipley, M. J., Alfredsson, L., Fransson, E. I., Goldberg, M., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.016 · Cited by 440
Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety
Huckvale, K., Venkatesh, S., & Christensen, H. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0166-1 · Cited by 433
Lyall, L. M., Wyse, C. A., Graham, N., Ferguson, A., Lyall, D. M., Cullen, B., Celis Morales, C. A., Biello, S. M., Mackay, D., Ward, J., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30139-1 · Cited by 418 · cited 1×
“68 Other monitoring sensor devices (e.g., actigraphy), can variously capture circadian rhythms, mood, global cognitive status, and sleep disruptions.”
Self-citationRadin, J. M., Wineinger, N. E., Topol, E. J., & Steinhubl, S. R. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30222-5 · Cited by 300
Marden, J. R., Tchetgen Tchetgen, E. J., Kawachi, I., & Glymour, M. M. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx155 · Cited by 284 · cited 1×
“Life-course predictors of dementia risk and onset are often addressed using longitudinal studies of aging such as the Health and Retirement Study, 11 Framingham Heart Study, 12 or the Alzheimer’s Disease Neuroimaging Initiative (ADNI 13 ).”
Identifying dementia cases with routinely collected health data: a systematic review
Wilkinson, T., Ly, A., Schnier, C., Rannikmäe, K., Bush, K., Brayne, C., Quinn, T. J., Sudlow, C. L. M., & On behalf of the UK Biobank Neurodegenerative Outcomes Group and Dementias Platform UK (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.016 · Cited by 279
Machine learning for comprehensive forecasting of Alzheimer’s Disease progression
Fisher, C. K., Smith, A. M., Walsh, J. R., Diseases, C. A. M., Simon, A. J., Edgar, C., Jack, C. R., Holtzman, D., Russell, D., Hill, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49656-2 · Cited by 223
Jackson, R., Kartoglu, I., Stringer, C., Gorrell, G., Roberts, A., Song, X., Wu, H., Agrawal, A., Lui, K., Groza, T., et al. (2018) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-018-0623-9 · Cited by 134
Decoupling the Role of Data, Attention, and Losses in Multimodal Transformers
Hendricks, L. A., Mellor, J., Schneider, R., Alayrac, J.-B., & Nematzadeh, A. (2021) · Transactions of the Association for Computational Linguistics · doi:10.1162/tacl_a_00385 · Cited by 100
Korologou-Linden, R., Bhatta, L., Brumpton, B. M., Howe, L. D., Millard, L. A. C., Kolaric, K., Ben-Shlomo, Y., Williams, D. M., Smith, G. D., Anderson, E. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32183-6 · Cited by 71
Automatic Subtyping of Individuals with Primary Progressive Aphasia
Themistocleous, C., Ficek, B., Webster, K., den Ouden, D.-B., Hillis, A. E., & Tsapkini, K. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201101 · Cited by 51
Sommerlad, A., Werbeloff, N., Perera, G., Smith, T., Costello, H., Mueller, C., Kormilitzin, A., Broadbent, M., Nevado‐Holgado, A., Lovestone, S., et al. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5625 · Cited by 14
Self-citation
Cited by
Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: a systematic review
Borchert, R. J., Azevedo, T., Badhwar, A., Bernal, J., Betts, M., Bruffaerts, R., Burkhart, M. C., Dewachter, I., Gellersen, H. M., Low, A., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13412 · Cited by 125
Self-citationAlzheimer's disease digital biomarkers multidimensional landscape and AI model scoping review
Qi, W., Zhu, X., Wang, B., Shi, Y., Dong, C., Shen, S., Li, J., Zhang, K., He, Y., Zhao, M., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01640-z · Cited by 78
Cheng, F., Wang, F., Tang, J., Zhou, Y., Fu, Z., Zhang, P., Haines, J. L., Leverenz, J. B., Gan, L., Hu, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101379 · Cited by 63
Artificial intelligence for dementia prevention
Newby, D., Orgeta, V., Marshall, C. R., Lourida, I., Albertyn, C. P., Tamburin, S., Raymont, V., Veldsman, M., Koychev, I., Bauermeister, S., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13463 · Cited by 42
Self-citation
Metadata
- Authors
- Lyall, D. M., Kormilitzin, A., Lancaster, C., Sousa, J., Petermann‐Rocha, F., Buckley, C., Harshfield, E. L., Iveson, M. H., Madan, C. R., McArdle, R., Newby, D., Orgeta, V., Tang, E., Tamburin, S., Thakur, L. S., Lourida, I., The Deep Dementia Phenotyping (DEMON) Network, Llewellyn, D. J., & Ranson, J. M.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2023-07-26
- Volume
- 19
- Issue
- 12
- Pages
- 5872-5884
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W4385294584
- Cited by
- 68
- References
- 31
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.